[Enterofuril eradication therapy in chronic inflammatory diseases of the upper digestive tract]

Eksp Klin Gastroenterol. 2011:(7):85-90.
[Article in Russian]
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / administration & dosage
  • 2-Pyridinylmethylsulfinylbenzimidazoles / therapeutic use
  • Adult
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use*
  • Chronic Disease
  • Clarithromycin / administration & dosage
  • Clarithromycin / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Gastritis / drug therapy*
  • Gastritis / microbiology
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / microbiology
  • Humans
  • Hydroxybenzoates / administration & dosage
  • Hydroxybenzoates / therapeutic use*
  • Male
  • Metronidazole / administration & dosage
  • Metronidazole / therapeutic use
  • Nitrofurans / administration & dosage
  • Nitrofurans / therapeutic use*
  • Pantoprazole
  • Peptic Ulcer / drug therapy*
  • Peptic Ulcer / microbiology
  • Treatment Outcome

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Infective Agents
  • Hydroxybenzoates
  • Nitrofurans
  • Metronidazole
  • Pantoprazole
  • Clarithromycin
  • nifuroxazide